Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid and advanced skin cancer. This FDA recap highlights recent approvals in April ...

Patients with psoriasis who had low body surface area (BSA) involvement experienced similarly poor QOL and symptom burden compared to patients with higher BSA.

The beauty brand's new Slather Bar is a solution to your bumpy skin, making smooth textures more accessible this summer.

In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.